Editorial Review |

The Drug Hypersensitivity Syndrome:  What Is the Pathogenesis?

John R. Sullivan, MB, BS, FACD; Neil H. Shear, MD, FRCPC
Arch Dermatol. 2001;137(3):357-364. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-137-3-der00006.
Text Size: A A A
Published online


Drug hypersensitivity syndrome (DHS) is a severe idiosyncratic reaction associated with drug therapy. Cutaneous eruptions are the most common idiosyncratic reaction to drugs, but DHS is not just a drug-related eruption. We defined DHS by the clinical triad of fever, rash, and internal organ involvement.1 The pathogenesis of this disease is not well defined; however, intriguing clinical and laboratory observations and associations provide insight into the mechanistic puzzle of this iatrogenic disease. The article in this issue by Descamps et al2 raises further questions as to this syndrome's association with viral infection. Understanding the pathomechanism of DHS is important for the prevention and improved management of these potentially life-threatening reactions.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
Figure 1.

The potential interplay of factors reported with drug hypersensitivity syndrome. Drug hypersensitivity reactions occur more commonly in women than in men in most studies.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

The potential role of reactive drug metabolites. Chemically reactive drug products usually constitute only a minor proportion of a drug's metabolites but are probably responsible for many serious adverse effects, including hypersensitivity reactions.

Graphic Jump Location




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 127

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles